Oral contraceptive use and risk of fractures

被引:23
|
作者
Vestergaard, Peter [1 ]
Rejnmark, Lars [1 ]
Mosekilde, Leif [1 ]
机构
[1] Aarhus Univ Hosp, Osteoporosis Clin, Aarhus Amtssygehus, Dept Endocrinol & Metab C, DK-8000 Aarhus C, Denmark
关键词
fracture; oral contraceptives; epidemiology; risk factors; confounders;
D O I
10.1016/j.contraception.2006.01.006
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Introduction: Prior studies have suggested that oral contraceptives (OCs) may be associated with an increased fracture risk. However, the previous studies have only performed a limited adjustment for other potential risk factors. Subjects and Methods: All women with a fracture (n=64,548) in the year 2000 in Denmark served as cases. For each case, three age-matched controls were randomly drawn from the general population (n = 193,641). Exposure was use of OCs between January 1, 1996, and December 31, 2000. Adjustments were made for use of other drugs, pregnancy, prior fracture, other diseases and social variables. Results: In the unadjusted analysis, use of OCs in low dose was associated with a small increase in overall fracture risk. However, upon adjustment, no increase in fracture risk could be demonstrated in any age or dose group. Conclusion: Oral contraceptives are not associated with an increase or a decrease in fracture risk. Any change in fracture risk may be due to confounders. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:571 / 576
页数:6
相关论文
共 50 条
  • [31] COMBINATION ORAL-CONTRACEPTIVE USE AND THE RISK OF ENDOMETRIAL CANCER
    LEE, NC
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (06): : 796 - 800
  • [32] Third generation oral contraceptive use and cardiovascular risk factors
    Döring, A
    Fröhlich, M
    Löwel, H
    Koenig, W
    ATHEROSCLEROSIS, 2004, 172 (02) : 281 - 286
  • [33] ORAL-CONTRACEPTIVE USE AND THE RISK OF CHLAMYDIAL AND GONOCOCCAL INFECTIONS
    LOUV, WC
    AUSTIN, H
    PERLMAN, J
    ALEXANDER, WJ
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1989, 160 (02) : 396 - 402
  • [34] Oral contraceptive use and breast cancer risk: Current status
    Cerhan, James R.
    MAYO CLINIC PROCEEDINGS, 2006, 81 (10) : 1287 - 1289
  • [35] ORAL-CONTRACEPTIVE USE AND THE RISK OF MYOCARDIAL-INFARCTION
    ROSENBERG, L
    PALMER, JR
    LESKO, SM
    SHAPIRO, S
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1990, 131 (06) : 1009 - 1016
  • [36] Timing of pregnancies and oral contraceptive use and risk of ovarian cancer
    Bodelon, Clara
    Risch, Harvey
    Modugno, Francesmary
    Webb, Penelope
    Pearce, Celeste Leigh
    Pike, Malcolm
    Wentzensen, Nicolas
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2017, 26 (05)
  • [37] Oral contraceptive (OC) use and risk of breast cancer - reply
    L Tryggvadóttir
    H Tulinius
    GB Gudmundsdóttir
    British Journal of Cancer, 1997, 76 : 417 - 418
  • [38] Oral contraceptive (OC) use and risk of breast cancer - Reply
    Tryggvadottir, L
    Tulinius, H
    Gudmundsdottir, GB
    BRITISH JOURNAL OF CANCER, 1997, 76 (03) : 417 - 418
  • [39] The risk of recurrent venous thrombosis associated with oral contraceptive use
    Vlieg, van Hylckama A.
    Flinterman, L. E.
    Cannegieter, S. C.
    Rosendaal, F. R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 173 - 173
  • [40] Breast Cancer Risk Related to Combined Oral Contraceptive Use
    Graafland, Laura
    Abbott, Maura
    Accordino, Melissa
    JNP-JOURNAL FOR NURSE PRACTITIONERS, 2020, 16 (02): : 116 - 120